While this slowing helps reduce appetite and blood sugar spikes, delayed gastric clearance can increase intragastric pressure and reflux frequency
[30] Why States Are Cutting Coverage State Medicaid programs are facing unsustainable costs from GLP-1 medications: Wegovy costs ~$1,350/month at list pricemultiplied across thousands of beneficiaries [6] Medicaid drug spending on GLP-1s has increased dramatically since 2020 [1] Budget constraints force states to make difficult coverage decisions Unlike commercial insurance , states can't spread costs across a broader risk pool According to KFF, states that do cover GLP-1s for obesity report significant budget impacts, leading several to reconsider or restrict coverage going forward
I also wouldnt prescribe them to people with untreated glucose control issues because of their effect on insulin resistance
Rather, its the resulting infection a particular issue among people with diabetes
Protein synthesisthe process your body uses to build new musclerequires adequate amino acid availability
Lipotropic injections are often used in weight management programs to help support liver function and enhance fat metabolism